Proinflammatory Cytokine Infusion Attenuates LH's Feedforward on Testosterone Secretion: Modulation by Age

J Clin Endocrinol Metab. 2016 Feb;101(2):539-49. doi: 10.1210/jc.2015-3611. Epub 2015 Nov 24.

Abstract

Context: In the experimental animal, inflammatory signals quench LH's feedforward drive of testosterone (T) secretion and appear to impair GnRH-LH output. The degree to which such suppressive effects operate in the human is not known.

Objective: To test the hypothesis that IL-2 impairs LH's feedforward drive on T and T's feedback inhibition of LH secretion in healthy men.

Setting: Mayo Center for Translational Science Activities.

Patients or other participants: A total of 35 healthy men, 17 young and 18 older.

Interventions: Randomized prospective double-blind saline-controlled study of IL-2 infusion in 2 doses with concurrent 10-minute blood sampling for 24 hours.

Main outcome measures: Deconvolution analysis of LH and T secretion.

Results: After saline injection, older compared with young men exhibited reduced LH feedforward drive on T secretion (P < .001), and decreased T feedback inhibition of LH secretion (P < .01). After IL-2 injection, LH's feedforward onto T secretion declined markedly especially in young subjects (P < .001). Concomitantly, IL-2 potentiated T's proportional feedback on LH secretion especially in older volunteers.

Conclusion: This investigation confirms combined feedforward and feedback deficits in older relative to young men given saline and demonstrates 1) joint mechanisms by which IL-2 enforces biochemical hypogonadism, viz, combined feedforward block and feedback amplification; and 2) unequal absolute inhibition of T and LH secretion by IL-2 in young and older men. These outcomes establish that the male gonadal axis is susceptible to dual-site suppression by a prototypic inflammatory mediator. Thus, we postulate that selected ILs might also enforce male hypogonadism in chronic systemic inflammation.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aging / physiology*
  • Cross-Over Studies
  • Cytokines / pharmacology*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Feedback, Physiological / drug effects*
  • Humans
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / adverse effects
  • Interleukin-2 / pharmacology*
  • Luteinizing Hormone / metabolism*
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • Testosterone / metabolism*
  • Young Adult

Substances

  • Cytokines
  • IL2 protein, human
  • Interleukin-2
  • Testosterone
  • Luteinizing Hormone